Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumab.
Kadota N, Hatakeyama N, Hino H, Kunishige M, Kondo Y, Okano Y, Machida H, Naruse K, Shinohara T, Sakiyama S, Ogushi F, Takeuchi E.
Kadota N, et al. Among authors: takeuchi e.
Cancer Rep (Hoboken). 2022 Aug;5(8):e1589. doi: 10.1002/cnr2.1589. Epub 2021 Nov 24.
Cancer Rep (Hoboken). 2022.
PMID: 34817132
Free PMC article.